P089. Neoadjuvant Pertuzumab in the treatment of HER2+ve breast cancer: Increased Pathological Complete Response, but at a cost?
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI